Astrazeneca Plc Adr Stock Price on October 28, 2024
| AZN Stock | USD 67.62 0.42 0.63% |
Below is the normalized historical share price chart for AstraZeneca PLC ADR extending back to May 12, 1993. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of AstraZeneca PLC stands at 67.62, as last reported on the 30th of November, with the highest price reaching 67.72 and the lowest price hitting 67.14 during the day.
If you're considering investing in AstraZeneca Stock, it is important to understand the factors that can impact its price. AstraZeneca PLC ADR secures Sharpe Ratio (or Efficiency) of -0.24, which signifies that the company had a -0.24% return per unit of risk over the last 3 months. AstraZeneca PLC ADR exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm AstraZeneca PLC's Risk Adjusted Performance of (0.19), mean deviation of 1.07, and Standard Deviation of 1.5 to double-check the risk estimate we provide.
At this time, AstraZeneca PLC's Total Stockholder Equity is very stable compared to the past year. As of the 30th of November 2024, Liabilities And Stockholders Equity is likely to grow to about 106.2 B, while Common Stock Shares Outstanding is likely to drop about 2.9 B. . As of the 30th of November 2024, Price Earnings To Growth Ratio is likely to grow to 0.47, while Price To Sales Ratio is likely to drop 4.37. AstraZeneca Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 12th of May 1993 | 200 Day MA 74.7795 | 50 Day MA 72.72 | Beta 0.18 |
AstraZeneca |
Sharpe Ratio = -0.2404
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AZN |
Estimated Market Risk
| 1.52 actual daily | 13 87% of assets are more volatile |
Expected Return
| -0.36 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.24 actual daily | 0 Most of other assets perform better |
Based on monthly moving average AstraZeneca PLC is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AstraZeneca PLC by adding AstraZeneca PLC to a well-diversified portfolio.
Price Book 5.149 | Enterprise Value Ebitda 15.7946 | Price Sales 4.0945 | Shares Float 1.5 B | Dividend Share 2.97 |
Related Headline
GlaxoSmithKline PLC Headline on 28th of October 2024
Why could a silent asthma epidemic be sweeping Africa by aljazeera.com
Millions of adolescents in Africa could be living unknowingly with asthma as cases go undiagnosed, researchers find.
AstraZeneca PLC Valuation on October 28, 2024
It is possible to determine the worth of AstraZeneca PLC on a given historical date. On October 28, 2024 AstraZeneca was worth 75.04 at the beginning of the trading date compared to the closed value of 76.01. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of AstraZeneca PLC stock. Still, in general, we apply an absolute valuation method to find AstraZeneca PLC's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of AstraZeneca PLC where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against AstraZeneca PLC's related companies.
| Open | High | Low | Close | Volume | |
| 75.67 | 75.78 | 74.95 | 75.05 | 3,208,645 | |
10/28/2024 | 75.04 | 76.63 | 74.94 | 76.01 | 5,073,851 |
| 75.44 | 75.79 | 75.05 | 75.22 | 2,813,386 |
| Backtest AstraZeneca PLC | | | AstraZeneca PLC History | | | AstraZeneca PLC Valuation | Previous | Next |
AstraZeneca PLC Trading Date Momentum on October 28, 2024
| On October 29 2024 AstraZeneca PLC ADR was traded for 75.22 at the closing time. Highest AstraZeneca PLC's price during the trading hours was 75.79 and the lowest price during the day was 75.05 . The net volume was 2.8 M. The overall trading history on the 29th of October contributed to the next trading period price depreciation. The overall trading delta to the next next day price was 1.04% . The overall trading delta to current price is 16.45% . |
AstraZeneca PLC ADR Fundamentals Correlations and Trends
By evaluating AstraZeneca PLC's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among AstraZeneca PLC's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. AstraZeneca financial account trend analysis is a perfect complement when working with valuation or volatility modules.About AstraZeneca PLC Stock history
AstraZeneca PLC investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for AstraZeneca is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in AstraZeneca PLC ADR will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing AstraZeneca PLC stock prices may prove useful in developing a viable investing in AstraZeneca PLC
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 3.1 B | 2.9 B | |
| Net Income Applicable To Common Shares | 3 B | 3.2 B |
AstraZeneca PLC Stock Technical Analysis
AstraZeneca PLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
AstraZeneca PLC Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
AstraZeneca PLC ADR cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
AstraZeneca PLC November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how AstraZeneca PLC stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading AstraZeneca PLC shares will generate the highest return on investment. By undertsting and applying AstraZeneca PLC stock market strength indicators, traders can identify AstraZeneca PLC ADR entry and exit signals to maximize returns
AstraZeneca PLC Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for AstraZeneca PLC's price direction in advance. Along with the technical and fundamental analysis of AstraZeneca Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of AstraZeneca to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.19) | |||
| Jensen Alpha | (0.38) | |||
| Total Risk Alpha | (0.64) | |||
| Treynor Ratio | 30.88 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AstraZeneca PLC ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AstraZeneca PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.034 | Dividend Share 2.97 | Earnings Share 2.08 | Revenue Per Share 2.7424 | Quarterly Revenue Growth 0.18 |
The market value of AstraZeneca PLC ADR is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.